The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

Peer Review reports

Original Submission
2 Nov 2021	Submitted	Original manuscript
7 Jan 2022	Reviewed	Reviewer Report - Felipe Castañeda
8 Jan 2022	Reviewed	Reviewer Report - Cheney J.G. Drew
10 Feb 2022	Author responded	Author comments - Maoyuan Sun
Resubmission - Version 2
10 Feb 2022	Submitted	Manuscript version 2
21 Feb 2022	Reviewed	Reviewer Report - Cheney J.G. Drew
9 Mar 2022	Author responded	Author comments - Maoyuan Sun
Resubmission - Version 3
9 Mar 2022	Submitted	Manuscript version 3
Publishing
10 Mar 2022	Editorially accepted
28 Mar 2022	Article published	10.1186/s13063-022-06168-1

Back to article page